Position in MLYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$39,355,077
+$18,088,263 QoQ
Shares Held
1,458,676
+85.8% QoQ
Ownership
1.65%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 224 holders
Holding Since
Mar 2023
12 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in MLYS Over Time
Shares Held
Position Value (USD)
Derivatives in MLYS
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$914,622
PutShares
33,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. MLYS ranks #79 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in MLYS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $914,622 | 33,900 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $39,355,077 | 1,458,676 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $918,351 | 33,900 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $21,266,814 | 785,043 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $26,986,184 | 711,661 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,480,427 | 626,787 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,738,511 | 298,395 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,377,673 | 111,915 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,083,251 | 89,451 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $664,829 | 56,823 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $636,346 | 49,291 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $392,031 | 45,585 | Shares | Defined | 2024-05-14 | |
| 2023-06-30 | $278,358 | 16,326 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $434,799 | 27,765 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||